NCT04656652 2026-02-05
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)
Daiichi Sankyo
Phase 3 Active not recruiting
Daiichi Sankyo
Bristol-Myers Squibb
Bristol-Myers Squibb